Targeting the miR-32533/CREB5 axis: a promising immunomodulatory and therapeutic strategy for Alzheimer’s disease - Quiz - MDSpire

Targeting the miR-32533/CREB5 axis: a promising immunomodulatory and therapeutic strategy for Alzheimer’s disease

  • By

  • Lizhen Li

  • Xiaolin Zhao

  • Li Zeng

  • Zixuan Li

  • Kaiyue Zhao

  • Zhongdi Cai

  • Rui Liu

  • May 4, 2026

  • 0 min

Share

Original Source(s)

Targeting the miR-32533/CREB5 axis: a promising immunomodulatory and therapeutic strategy for Alzheimer’s disease

  • by Lizhen Li, Xiaolin Zhao, Li Zeng, Zixuan Li, Kaiyue Zhao, Zhongdi Cai, Rui Liu

  • May 4, 2026

Related Content

Towards a speech-based digital biomarker for cognitive impairment: speech as a proxy for cognitive assessment

The immune-endothelial axis in neurovascular pathophysiology: a framework for targeted interventions

Wearable EEG devices in the detection of mild cognitive impairment: a systematic review